Aug 09, 2017 08:34 am UTC| Business
Dublin, Aug. 09, 2017 -- The "Drug Testing: Technologies and Global Markets" report has been added to Research and Markets' offering. Report Includes An overview of the...
Aug 09, 2017 07:01 am UTC| Business
NEW YORK and ZURICH, Switzerland, Aug. 09, 2017 -- SIX Swiss Exchange and Nasdaq, Inc. (Nasdaq:NDAQ) today have announced that Nasdaq, in collaboration with its technology partner Chain, will provide distributed ledger...
Yandex and Sberbank Join Forces to Boost eCommerce Development
Aug 09, 2017 07:00 am UTC| Business
MOSCOW, Russia and AMSTERDAM, the Netherlands, Aug. 09, 2017 -- Yandex and Sberbank announced today that the two companies have signed a non-binding term sheet to form a joint venture based on the Yandex.Market...
Nidec to Succeed the Business of Tokyo Maruzen Industry Co., Ltd.
Aug 09, 2017 06:30 am UTC| Business
KYOTO, Japan, Aug. 09, 2017 -- Nidec Corporation (TSE:6594) (OTC US:NJDCY) (the “Company” or “Nidec”) resolved at a meeting of Board of Directors held on August 9, 2017 to make Nidec Sankyo Corporation (“Nidec Sankyo”),...
DeNA Reports First Quarter, Fiscal Year 2017 Financial Results
Aug 09, 2017 06:10 am UTC| Business
TOKYO, Aug. 09, 2017 -- DeNA Co., Ltd. (Tokyo:2432) today announced its IFRS and non-GAAP financial results for the quarter ended June 30, 2017. DeNA reported quarterly IFRS revenue of 36.5 billion yen, IFRS operating...
Motif Bio’s second Phase 3 clinical trial in ABSSSI finishes patient treatment phase
Aug 09, 2017 06:00 am UTC| Business
NEW YORK, Aug. 09, 2017 -- Motif Bio plc (AIM:MTFB) (NASDAQ:MTFB), the clinical stage biopharmaceutical company specialising in developing novel antibiotics, announced today that the last patient has completed the...
Statoil ASA: Ex dividend and ex rights to participate in dividend issue
Aug 09, 2017 05:59 am UTC| Business
From 9 August 2017, the shares in Statoil (OSE: STL, NYSE: STO) at Oslo Børs (Oslo Stock Exchange) will be traded ex dividend USD 0.2201 and ex rights to participate in the dividend issue (scrip dividend programme) for...